— Know what they know.
Not Investment Advice
Also trades as: EQRXW (NASDAQ) · $vol 0M

EQRX NASDAQ

EQRx, Inc.
1W: +0.0% 1M: +5.4% 3M: +4.5% 1Y: -57.9%
$2.34
Last traded 2023-11-09 — delisted
NASDAQ · Healthcare · Biotechnology · $1.1B mcap · 279M float · 1.61% daily turnover

Income Trends

Revenue
$0 +0.0% ▲
Gross Profit
$0 +0.0% ▲
Operating Income
-$356M -81.2% ▼
Net Income
$205M +326.6% ▲
EPS (Diluted)
$0.43 +253.6% ▲
EBITDA
-$356M -81.2% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2019FY2020FY2021FY2022
Revenue$0$0$0$0
YoY Growth+0.0%+0.0%+0.0%+0.0%
Cost of Revenue$0$0$0$0
Gross Profit$0$0$0$0
Gross Margin————
R&D Expenses$3K$224M$118M$228M
SG&A Expenses$10K$26M$78M$127M
Operating Expenses$26K$250M$196M$356M
Operating Income-$14K-$250M-$196M-$356M
Operating Margin————
Interest Expense$0$0$0$25M
Income Before Tax-$26K-$250M-$100M-$169M
Tax Expense$0-$97K-$9M-$375M
Net Income-$26K-$250M-$91M$205M
Net Margin————
EPS (Diluted)$-0.00$-0.80$-0.28$0.43
EBITDA-$12K-$250M-$196M-$356M
Shares Outstanding426M311M481M474M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms